# Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)

> **NCT03686020** · — · UNKNOWN · sponsor: **Cairo University** · enrollment: 24 (estimated)

## Conditions studied

- Oral Potentially Malignant Lesions
- Oral Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Enzyme Linked Immunosorbent assay (ELISA)

## Key facts

- **NCT ID:** NCT03686020
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-23
- **Primary completion:** 2019-10
- **Final completion:** 2019-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686020, "Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03686020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*